| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Financial Highlights for the Full Year Ending December 31, 2023:
Total revenue for the twelve months ended December 31, 2023 totaled approximately $6.0 million, a decrease of $1.3 million compared to total revenue for the twelve months ended December 31, 2022. This decrease was primarily driven by the timing of fixed price milestone contracts offset by satellite payload revenue.
Cost of revenue decreased 26% for the twelve months ended December 31, 2023 to approximately $4.3 million as compared to approximately $5.9 million for the twelve months ended December 31, 2022. The decrease was primarily driven by a mix of contracts and an increase in our higher margin satellite related business, which helped offset continued increased supply chain related costs in the manufacturing side of our business.
Gross profit increased 14% for the twelve months ended December 31, 2023 to approximately $1.6 million as compared to approximately $1.4 million for the twelve months ended December 31, 2022. Gross profit margin increased to 28% for the full year 2023 as compared to 20% for the full year 2022. This improvement was driven by an increase in the Company's higher margin satellite business.
Selling, general, and administrative expenses for the twelve months ended December 31, 2023 totaled $14.2 million as compared to $13.5 million for the same period the prior year. The increase was primarily due to an increase in professional fees, including legal costs, associated with the acquisition of Exo-Space, as well as an increase in fundraising and employee expenses. This was offset by a decrease in insurance rates, license fees, and IR/PR expenses.
Adjusted EBITDA loss, a non-GAAP measure, for the twelve months ended December 31, 2023 totaled $10.9 million as compared to an Adjusted EBITDA loss of $9.7 million for the same period the prior year. Total non-GAAP adjustments for interest expense, depreciation and amortization, acquisition deal costs, severance costs, capital markets and advisory fees, equity-based compensation, and warrant costs are provided in the reconciliation table below.
Net loss for the twelve months ended December 31, 2023 was $14.3 million as compared to a net loss of $12.8 million for the same period the prior year.
Balance Sheet:
At December 31, 2023, the Company had cash of $1.2 million as compared to $2.3 million at December 31, 2022. Subsequent to December 31, 2023, the Company received gross proceeds of $15.2 million through the exercise of warrants and two offerings.
Accounts Payable and other current liabilities was $6.7 million at December 31, 2023, as compared to $3.4 million at December 31, 2022. Asset-based loan liability was $2.6 million at December 31, 2023 as compared to $502 thousand at December 31, 2022. Notes payable was $2 million at December 31, 2023 as compared to $1.6 million at December 31, 2022. These increases were primarily due to timing of vendor payments, increased utilization of our asset-based loan and accrued interest expense related to our note payable.
Posted In: SIDU
